, BGRIM received total 10 national and international awards in a number of categories including Best Renewable Projects, Green Bond Financing, Best CEO and Best IR Team together with 7 ESG recognitions and

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

in financing activities was THB 1,030mn mainly from proceeds from the increase in share capital of THB 2,040mn. However, this offset by a decrease in short-term as well as long-term loans from

from 2Q2017. As a final point, consolidated net profit in 2Q2018 accounted for THB 211.58 million or equal to EPS of THB 0.17 per share, or 57.15% down from 2Q2017. For capital structure of the Group, as

74.67 57.77 8.23 GP 251.48 24.86 238.28 25.33 13.20 5.54 EBITDA 159.88 15.81 159.88 17.00 - - EBIT 100.80 9.97 98.15 10.44 2.65 2.70 NP 79.64 7.87 76.71 8.16 2.93 3.82 EPS (Baht per Share) * 0.08 0.08

) (20.63) EPS (Baht per Share) * 0.18 0.22 (0.04) (18.18) Weighted Average Number of Ordinary Shares (Million Shares) * 947.96 947.96 - - Return on Equity (ROE) (%) 28.71% 26.37% 2.34% Return on Assets (ROA

THB 375. 61 million or equal to EPS of THB 0. 30 per share, or 14. 02% down from 3Q2018. For capital structure of the Group, as at September 30, 2019, the consolidated debt to equity ratio was 0.40 time

Revenues 8,770 6,755 446 322 9,216 7,077 2,139 30% Total Expenses (8,664) (6,715) (378) (292) (9,042) (7,007) 2,035 29% Share of Profit (Loss) 1,775 1,688 27 19 1,802 1,707 95 6% Gain on disposal of

8,016 5,337 2,679 50% Total Expenses (7,221) (4,956) (156) (126) (7,377) (5,082) 2,295 45% Share of Profit (Loss) 2,417 2,037 12 4 2,429 2,041 388 19% Profit (Loss) before FX, deferred income tax

1,586.14 -12.47 -0.8% Earning before interest and tax 65.39 90.65 -25.26 -27.9% 137.31 166.19 -28.88 -17.4% Financial expenses -1.30 -1.38 0.08 -5.8% -2.63 -3.03 0.40 -13.2% Share of income from investment